APAC Biguanide Market Share

Statistics for the 2023 & 2024 APAC Biguanide market share, created by Mordor Intelligence™ Industry Reports. APAC Biguanide share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of APAC Biguanide Industry

The Asia-Pacific biguanide market is fragmented, with manufacturers like Takeda, Merck, Sanofi, GlaxoSmithKline, Bristol-Myers Squibb, and Boehringer Ingelheim Pharmaceuticals having a global market presence and the market is highly competitive due to other generic drugs manufacturers' presence.

APAC Biguanide Market Leaders

  1. Takeda

  2. Bristol-Myers Squibb

  3. Glenmark

  4. Merck and Co.

  5. Sanofi Aventis

*Disclaimer: Major Players sorted in no particular order

APAC Biguanide Market Concentration

APAC Biguanide Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)